Immunogen reported $42.06M in Selling and Administration Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US USD 3.21B 4M
Agios Pharmaceuticals AGIO:US USD 32.77M 3.65M
Amgen AMGN:US USD 1.47B 181M
Astellas Pharma 4503:JP JPY 163.02B 8.46B
AstraZeneca AZN:LN USD 3.53B 174M
Bluebird Bio BLUE:US USD 33.4M 3.29M
Bristol Myers Squibb BMY:US USD 2.27B 336M
Eli Lilly And LLY:US USD 1.64B 29M
Emergent Biosolutions EBS:US USD 94.2M 14M
Exelixis EXEL:US USD 119.25M 4.27M
Halozyme Therapeutics HALO:US USD 36.35M 2.28M
Heron Therapeutics HRTX:US USD 28.18M 3.94M
Immunogen IMGN:US USD 42.06M 8.44M
Intrexon XON:US USD 11.51M 1.37M
Karyopharm Therapeutics KPTI:US USD 34.65M 4K
Macrogenics MGNX:US USD 13.67M 1.68M
Nektar Therapeutics NKTR:US USD 21.94M 595K
Novartis NVS:US USD 3.7B 295M
Pfizer PFE:US USD 4.87B 1.33B
Regeneron Pharmaceuticals REGN:US USD 660.5M 131.4M
Roche Holding ROG:VX 6.48B 834M
Seattle Genetics SGEN:US USD 216.1M 5.72M